ArriVent BioPharma, Inc.
AVBP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001868279
No open-market purchases or sales by ArriVent BioPharma, Inc. insiders were filed in the last 90 days; 157 institutions reported holding it in 13F filings for Q2 2026, worth $1.60B in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
13F holders, Q4 2025
Institutional positions in ArriVent BioPharma, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 122
- +16 vs. Q3 2025
- Shares held
- 40.1M
- +1.54M (+4.0%) vs. Q3 2025
- Total value
- $810.3M
- +$97.9M (+13.7%) vs. Q3 2025
- New holders
- 30
- 41 more added
- Sold out
- 14
- 35 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AVBP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 157 | $1.60B |
| Q1 2026 | 139 | $969.5M |
| Q4 2025 | 122 | $810.3M |
| Q3 2025 | 106 | $712.4M |
| Q2 2025 | 99 | $732.0M |
| Q1 2025 | 83 | $539.3M |
| Q4 2024 | 80 | $757.5M |
| Q3 2024 | 68 | $612.3M |
| Q2 2024 | 54 | $404.2M |
| Q1 2024 | 53 | $388.9M |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding ArriVent BioPharma, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Northern Trust Corp | 245,599 | $4.94M | 0.00% | +14,432+6.2% | Added |
| Charles Schwab Investment Management Inc | 250,588 | $5.04M | 0.00% | +7,102+2.9% | Added |
| Millennium Management LLC | 281,952 | $5.67M | 0.00% | −4,152−1.5% | Reduced |
| UBS Group AG | 450,920 | $9.07M | 0.00% | −46,681−9.4% | Reduced |
| Citadel Advisors LLC | 458,502 | $9.23M | 0.01% | +458,502 | New |
| Fund 1 Investments, LLC | 565,851 | $11.4M | 1.65% | −54,000−8.7% | Reduced |
| AIHC Capital Management Ltd | 644,788 | $13.0M | 12.16% | +644,788 | New |
| Goldman Sachs Group Inc | 742,526 | $14.9M | 0.00% | +310,587+71.9% | Added |
| Geode Capital Management, LLC | 753,519 | $15.2M | 0.00% | +37,231+5.2% | Added |
| SC China Holding Ltd | 663,308 | $16.7M | 0.98% | 00.0% | Unchanged |
| State Street Corp | 1,091,980 | $22.0M | 0.00% | +64,352+6.3% | Added |
| General Catalyst Group Management, LLC | 1,494,786 | $30.1M | 13.56% | 00.0% | Unchanged |
| Sofinnova Investments, Inc. | 1,696,752 | $34.1M | 1.47% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,869,266 | $37.6M | 0.00% | −160,265−7.9% | Reduced |
| Novo Holdings A/S | 1,942,142 | $39.1M | 3.03% | 00.0% | Unchanged |
| Octagon Capital Advisors LP | 1,971,054 | $39.7M | 4.96% | 00.0% | Unchanged |
| BlackRock, Inc. | 2,372,838 | $47.7M | 0.00% | +326,700+16.0% | Added |
| OrbiMed Advisors LLC | 3,027,328 | $60.9M | 1.25% | 00.0% | Unchanged |
| FMR LLC | 3,703,572 | $74.5M | 0.00% | +296,023+8.7% | Added |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 3,929,117 | $79.1M | 2.55% | −555,555−12.4% | Reduced |
| Suvretta Capital Management, LLC | 4,106,035 | $82.6M | 2.06% | +402,583+10.9% | Added |
| Infinitum Asset Management, LLC | 4,123,923 | $83.0M | 12.28% | +255,000+6.6% | Added |
| Bessemer Group Inc | 0 | $0 | 0.00% | −1,395−100.0% | Sold out |
| Siren, L.L.C. | 0 | $0 | 0.00% | −700,000−100.0% | Sold out |
| Cooperman Leon G | 0 | $0 | 0.00% | −421,278−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −256,422−100.0% | Sold out |
| CI Private Wealth, LLC | 0 | $0 | 0.00% | −33,500−100.0% | Sold out |
| Corient IA LLC | 0 | $0 | 0.00% | −33,500−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −15,045−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −7,000−100.0% | Sold out |
| Wexford Capital LP | 0 | $0 | 0.00% | −1,567−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −82−100.0% | Sold out |
| Principal Securities, Inc. | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| Montag A & Associates Inc | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −1−100.0% | Sold out |